S. Antonia

Phase I/II study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung cancer (SCLC): CA209-032.

P. Ascierto, P. Ott, M. Pietanza, 2015 .

Phase I study of peposertib and avelumab with or without palliative radiotherapy in patients with advanced solid tumors

R. Aljumaily, S. Antonia, A. Machl, 2024, ESMO open.

Symptomatic Pneumonitis With Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III NSCLC

J. Naidoo, A. Villegas, C. Wadsworth, 2024, JTO clinical and research reports.

A phase 2 study of docetaxel in combination with indoximod in metastatic breast cancer.

W. J. Ramsey, C. Link, S. Antonia, 2014 .

A phase I study of indoximod in combination with docetaxel in metastatic solid tumors.

W. J. Ramsey, E. Dees, E. Jackson, 2013 .

Overcoming tumor antigen anergy in human malignancies using the novel indeolamine 2,3-dioxygenase (IDO) enzyme inhibitor, 1-methyl-D-tryptophan (1MT).

S. Antonia, H. Soliman, D. Sullivan, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.